Future Science GroupBrowse
Supplementary data.docx (1.59 MB)
Download file

Supplementary information. Development and in vivo evaluation of fused benzazole analogues of anti-melanoma agent HA15

Download (1.59 MB)
figure
posted on 07.06.2021, 11:37 by Cyril Ronco, Antoine Millet, Nedra Tekaya, Mauro safir-filho, Elisa Cavazza, Patricia Abbe, Johanna Ruediger, Magali Plaisant, Julie Mayen, Stéphane Rocchi, Rachid Benhida
Spectra of synthesized compounds
Figure S1. Average tumor weight removed from euthanized mice after 31 days of treatment with vehicle (Labrafil) and compound 10b. Adapted with permission from ref 11 (main article) Copyright (2016), American Chemical Society.

Funding

Cancéropôle PACA

Institut National Du Cancer INCA-PRTK program

Université Côte d'Azur IDEX UCA-JEDI innovation program

History

References

Usage metrics

Read the peer-reviewed publication

Development and in vivo evaluation of fused benzazole analogues of anti-melanoma agent HA15
Future Medicinal ChemistryFuture Medicinal Chemistry

Categories

Keywords

Antimelanoma AgentHA15benzazole derivativesantineoplastic activitymice xenograftsCancer Cell BiologyMolecular TargetsBasic PharmacologyPharmaceutical Sciences

Licence

CC BY-NC-ND 4.0

Exports